Signaling mechanisms of μ-opioid receptor (MOR) in the hippocampus: disinhibition versus astrocytic glutamate regulation

被引:0
作者
Min-Ho Nam
Woojin Won
Kyung-Seok Han
C. Justin Lee
机构
[1] Korea Institute of Science and Technology,Center for Neuroscience
[2] Korea University,KU
[3] Center for Cognition and Sociality,KIST Graduate School of Converging Science and Technology
[4] Institute for Basic Science,Department of Medical Biotechnology
[5] Dongguk University-Gyeongju,undefined
来源
Cellular and Molecular Life Sciences | 2021年 / 78卷
关键词
μ-opioid receptor; Hippocampus; Astrocyte; Disinhibition; Glutamate; LTP;
D O I
暂无
中图分类号
学科分类号
摘要
μ-opioid receptor (MOR) is a class of opioid receptors that is critical for analgesia, reward, and euphoria. MOR is distributed in various brain regions, including the hippocampus, where traditionally, it is believed to be localized mainly at the presynaptic terminals of the GABAergic inhibitory interneurons to exert a strong disinhibitory effect on excitatory pyramidal neurons. However, recent intensive research has uncovered the existence of MOR in hippocampal astrocytes, shedding light on how astrocytic MOR participates in opioid signaling via glia-neuron interaction in the hippocampus. Activation of astrocytic MOR has shown to cause glutamate release from hippocampal astrocytes and increase the excitability of presynaptic axon fibers to enhance the release of glutamate at the Schaffer Collateral-CA1 synapses, thereby, intensifying the synaptic strength and plasticity. This novel mechanism involving astrocytic MOR has been shown to participate in hippocampus-dependent conditioned place preference. Furthermore, the signaling of hippocampal MOR, whose action is sexually dimorphic, is engaged in adult neurogenesis, seizure, and stress-induced memory impairment. In this review, we focus on the two profoundly different hippocampal opioid signaling pathways through either GABAergic interneuronal or astrocytic MOR. We further compare and contrast their molecular and cellular mechanisms and their possible roles in opioid-associated conditioned place preference and other hippocampus-dependent behaviors.
引用
收藏
页码:415 / 426
页数:11
相关论文
共 558 条
  • [71] Riedl M(2003)Differential involvement of the mu and kappa opioid receptors in spatial learning Genes Brain Behav 205 415-72
  • [72] Chakrabarti S(2008)Layer selective presynaptic modulation of excitatory inputs to hippocampal cornu Ammon 1 by mu-opioid receptor activation Neuroscience 38 217-111
  • [73] Lee JH(2015)Effect of acute fentanyl treatment on synaptic plasticity in the hippocampal CA1 region in rats Front Pharmacol 111 1313-2962
  • [74] Nakano AH(2001)Opioid-mediated facilitation of long-term depression in rat hippocampus J Pharmacol Exp Ther 30 787-79
  • [75] Dado RJ(1995)Depression of LTP in rat dentate gyrus by naloxone is reversed by GABAA blockade Brain Res 136 389-7584
  • [76] Loh HH(1979)Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons Science 117 68-1026
  • [77] Law PY(2015)Understanding opioid reward Trends Neurosci 180 107-342
  • [78] Wessendorf MW(1997)The development of a conditioned place preference to morphine: effects of lesions of various CNS sites Behav Neurosci 24 2953-1010
  • [79] Elde R(1988)Conditioned place preference produced by intra-hippocampal morphine Pharmacol Biochem Behav 157 70-794
  • [80] Garzon M(2002)Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference Behav Brain Res 97 7579-87